Daily Headlinez Top News Updates
It begins with an Instagram reel: an influencer touting the most potent weight-loss peptides. Two taps, and the feed is flooded with peptide-fuelled weight-loss journeys. Then the descent into rabbit hole begins: YouTube explainers, AIsimplified scientific papers, Reddit thread obsessions, private chat groups. It ends with a shipment from China of powdered weight-loss medication, unapproved,…
NEW DELHI: The new generation of weight-loss injections — already popular globally — is now showing strong results in Indian patients too. A fresh study from a Delhi hospital finds that more than 4 in 10 people lost at least 10% of their body weight, a level doctors say can significantly improve overall health.The research,…
NEW DELHI : Weight-loss therapy costs are set to reduce substantially by up to 90%, with generic versions of injectable semaglutide are expected to hit pharmacy shelves from March 21. The move kicks off one of the most closely watched price wars in the high-stakes obesity and diabetes drug market.This is in the wake of…
India has officially approved the use of Ozempic (semaglutide), a once-a-week injection designed for adults with type 2 diabetes. Approved by the Central Drugs Standard Control Organisation (CDSCO), this drug has made headlines worldwide not just for diabetes management but also for its weight loss effects. As India faces rising rates of diabetes, Ozempic’s arrival…
NEW DELHI: The World Health Organization (WHO) has included popular weight-loss drugs like Semaglutide and Tirzepatide, sold in India under the brand name Wegovy and Mounjaro, respectively, in its Model List of Essential Medicines (EML).This is important because the WHO’s model list of essential medicines serves as a basis for public sector procurement, supply of…
